Journals / Health Sciences Quarterly / 2023 / Cilt: 3 - Sayı: 1

Significance of laboratory biomarkers in monitoring patients with COVID-19 pneumonia

Pages
13–25
Publication Date
2023-01-08
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

High NLR, SII, AIP, CAR, and MHR values may indicate low prognosis in COVID-19 patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Clinical and laboratory parameters are useful tools to improve success rates in the management of COVID-19 patients.
📊
Key Findings & Data:Indices such as NLR, PLR, MHR, SII, AIP and CAR may indicate poor prognosis in predicting poor prognosis in COVID-19.
💡
Conclusion & Impact:High NLR, SII, AIP, CAR, and MHR values may indicate low prognosis in COVID-19 patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Biochemical indexes · COVID-19 · laboratory parameter

Abstract

Clinical and laboratory parameters are useful tools to improve success rates in the management of COVID-19 patients. Indices such as NLR, PLR, MHR, SII, AIP and CAR may indicate poor prognosis in predicting poor prognosis in COVID-19. It was aimed to identify such parameters of disease progression in COVID-19 patients by examining demographic data, comorbid conditions, some biochemical and hematological parameters. A retrospective analysis was performed for patients admitted to intensive care unit or pulmonary diseases department or treated on an outpatient basis due to a diagnosis of COVID-19. Patients with positive PCR test and thoracic CT compatible with COVID-19 pneumonia were included in the study. A control group was formed from volunteers of similar age and gender. The study population was divided into four groups as follows: patients admitted to intensive care unit (ICU group); patients admitted to chest diseases department (Inpatient Group); patients treated on an outpatient basis (Outpatient Group); and controls (Control Group). There were 61, 201, and 30 patients in the ICU, inpatient, and outpatient groups, respectively. A total of 96 subjects served as controls. Study groups were comparable with respect to gender distribution. ICU patients had higher NLR, PLR, AIP, SII, and CAR, and lower LMR as compared to other groups. NLR, SII, AIP, and CAR emerged as predictors of ICU admission, while MHR was predictive of inpatient treatment. Certain clinical and laboratory parameters may be useful tools for improving the success of COVID-19 management. High NLR, SII, AIP, CAR, and MHR values may indicate low prognosis in COVID-19 patients.

🔖

Cite This Article

ÖLMEZ, H., TOSUN, M. (2023). Significance of laboratory biomarkers in monitoring patients with COVID-19 pneumonia. Health Sciences Quarterly, Cilt: 3 - Sayı: 1, 13–25. https://ajindex.com/articles/880820

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Lu R, Zhao X, Li J, Niu P, Yang B, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565-74. doi: 10.1016/S0140-6736(20)30251-8.
  2. Zhu N, Zhang D, Wang W, Li X, Yang B, et al. A novel coronavirus from patients with pneumonia in China, 2019. New England J Med. 2020;382(8):727-33. doi: 10.1056/NEJMoa2001017. Hassan SA, Sheikh FN, Jamal S, Ezeh JK, Akhtar A. Coronavirus (COVID-19): A Review of clinical features, diagnosis, and treatment. Cureus. 2020;12(3):e7355. doi: 10.7759/cureus.7355. ACR Recommendations for the use of Chest Radiography and Computed Tomography (CT) for Suspected COVID-19 Infection, American College of Radiology. Accessed May 25, 2020. https://www.acr.org/Advocacy-and-Economics/ ACR-Position-Statements/Recommendationsfor-Chest-Radiography-and-CT-for-SuspectedCOVID-19-Infection. Sun P, Qie S, Liu Z, Ren J, Li K, et al. Clinical characteristics of hospitalized patients with SARS‐ CoV‐2 infection: a single arm meta‐analysis. J Med Virol. 2020;92 6):612-7. doi: 10.1002/jmv.25735. Gao Y, Li T, Han M, Li X, Wu D, et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol. 2020;92(7):791-6. doi: 10.1002/jmv.25770. Fu J, Kong J, Wang W, Wu M, Yao L, et al. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China. Thrombosis Res. 2020;192:3-8. doi: 10.1016/j. thromres.2020.05.006. Bi X, Su Z, Yan H, Du J, Wang J et al. Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count. Platelets. 2020;31(5):674-9. doi: 10.1080/09537104.2020.1760230. Liu F, Li L, Xu MD, Wu J, Luo D, et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol. 2020;127:104370. doi: 10.1016/j. jcv.2020.104370. Aziz M, Fatima R, Lee-Smith W, Assaly R. The association of low serum albumin level with severe COVID-19: a systematic review and metaanalysis. Crit Care. 2020;24(1):255. doi: 10.1186/ s13054-020-02995-3.
  3. Usul E, San I, Bekgoz B, Sahin A. Role of hematological parameters in COVID-19 patients in the emergency room. Biomark Med. 2020;14(13):1207-15. doi: 10.2217/bmm-2020-0317.
  4. Peng J, Qi | Di, Yuan G, Deng X, Mei Y, et al. Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID‐19): A mul